Dolutegravir-based antiretroviral therapy does not reduce plasma levonorgestrel or medroxyprogesterone acetate concentrations among contraceptive users living with HIV compared with HIV-negative controls

被引：0
|
作者：
Ryan, Rebecca [1 ]
Mussa, Aamirah [1 ]
Bame, Bame [1 ]
Bapabi, Mbapi [1 ]
Moshashane, Neo [1 ]
Mechie, Imogen [1 ]
Ensor, Samuel [1 ]
Ndlovu, Neo [1 ]
Chakona, Shelby [1 ]
Simon, Selebaleng [1 ]
Tsuaneng, Maipelo [1 ]
Else, Laura [2 ]
Amara, Alieu [2 ]
Tatipamula, Vinay [2 ]
Dickinson, Laura [2 ]
Khoo, Saye [2 ]
Morroni, Chelsea [3 ]
机构：
[1] Botswana Harvard Hlth Partnership, Botswana Sexual & Reprod Hlth Initiat, Gaborone, Botswana
[2] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool, Merseyside, England
[3] Univ Edinburgh, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2024年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P196
引用
收藏
页码：187 / 187
页数：1
相关论文
共 43 条
  • [1] Etonogestrel concentrations among contraceptive implant users in Botswana using and not using dolutegravir-based antiretroviral therapy
    Bishop, Ian J.
    Gertz, Alida M.
    Simon, Boikhutso
    Tawe, Leabaneng
    Lechiile, Kwana
    Liu, Serena
    Teodoro, Nicholas
    Mussa, Aamirah
    Avalos, Ava
    Malima, Sifelani
    Maotwe, Tshego
    Mokganya, Lesego
    Westhoff, Carolyn L.
    Morroni, Chelsea
    CONTRACEPTION, 2020, 102 (03) : 174 - 179
  • [2] Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi
    Zia, Yasaman
    Tang, Jennifer H.
    Chinula, Lameck
    Tegha, Gerald
    Stanczyk, Frank Z.
    Kourtis, Athena P.
    CONTRACEPTION, 2019, 100 (05) : 402 - 405
  • [3] Metabolic Syndrome and Associated Factors Among People Living With HIV on Dolutegravir-Based Antiretroviral Therapy in Northern Tanzania
    Mirai, Tumaini E.
    Kilonzo, Kajiru G.
    Sadiq, Abid M.
    Muhina, Ibrahim Ali Ibrahim
    Kyala, Norman J.
    Marandu, Annette A.
    Gharib, Sarah K.
    Costantine, Andrea R.
    Mkwizu, Elifuraha W.
    Howlett, William P.
    Shao, Elichilia R.
    Nyakunga, Gissela B.
    Akrabi, Huda F.
    Kshettry, Vibhu R.
    Maro, Venance P.
    Chamba, Nyasatu G.
    Lyamuya, Furaha S.
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2024, 23
  • [4] Prevalence and factors associated with hyperglycemia among persons living with HIV/AIDS on dolutegravir-based antiretroviral therapy in Uganda
    Byereta, Lillian Happy
    Olum, Ronald
    Mutebi, Edrisa Ibrahim
    Kalyesubula, Robert
    Kagimu, Majid
    Meya, David B.
    Andia-Biraro, Irene
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2024, 11
  • [5] Treatment outcomes of low-level viremia among adults living with HIV on dolutegravir-based first line antiretroviral therapy in Botswana
    Bareng, Ontlametse T.
    Moyo, Sikhulile
    Mudanga, Mbatshi
    Sebina, Kagiso
    Koofhethile, Catherine
    Choga, Wonderful
    Gobe, Irene
    Motswaledi, Modisa
    Maruapula, Docas
    Moraka, Natasha
    Musonda, Rosemary
    Nkomo, Joseph
    Ramaabya, Dinah
    Chebani, Tony
    Makuruetsa, Penny
    Makhema, Joseph
    Gaseitsiwe, Simani
    BMJ GLOBAL HEALTH, 2023, 8 (SUPPL_10): : A24 - A24
  • [6] High prevalence of HIV drug resistance among people living with HIV on dolutegravir-based antiretroviral therapy with viral load above 200 copies/mL in Francistown, Botswana
    Choga, Ontlametse T.
    Lemogang, Goitseone M.
    Choga, Wonderful T.
    Muzanywa, Gaonyadiwe
    Shadreck, Thembinkosi M.
    Ralegoreng, Charity
    Maruapula, Dorcas
    Moraka, Natasha O.
    Koofhethile, Catherine K.
    Mokgethi, Patrick T.
    Seru, Kedumetse
    Zuze, Boitumelo
    Montshosi, Patience
    Gobe, Irene
    Motswaledi, Modisa S.
    Musonda, Rosemary
    Chebani, Tony
    Nawa, Judith
    Bochena, Lindani
    Moyo, Sikhulile
    Gaseitsiwe, Simani
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 124 - 126
  • [7] High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in Francistown, Botswana
    Choga, Ontlametse T.
    Lemogang, Goitseone M.
    Choga, Wonderful T.
    Muzanywa, Gaonyadiwe
    Shadreck, Thembinkosi M.
    Ralegoreng, Charity
    Maruapula, Dorcas
    Moraka, Natasha O.
    Koofhethile, Catherine K.
    Mokgethi, Patrick T.
    Seru, Kedumetse
    Zuze, Boitumelo J. L.
    Montshosi, Patience
    Gobe, Irene
    Motswaledi, Modisa S.
    Musonda, Rosemary
    Mbulawa, Mpaphi B.
    Makhema, Joseph
    Shapiro, Roger
    Lockman, Shahin
    Chebani, Tony
    Nawa, Judith
    Bochena, Lindani
    Moyo, Sikhulile
    Gaseitsiwe, Simani
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2025, 80 (03) : 767 - 776
  • [8] Viral suppression among adults with HIV receiving dolutegravir-based antiretroviral therapy and 3HP in Kampala, Uganda
    Chaisson, L.
    Semitala, F.
    Dowdy, D.
    Aman, K.
    Steinmetz, S.
    Armstrong, D.
    Opira, B.
    Kamya, M.
    Phillips, P.
    Yoon, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 74 - 75
  • [9] Dolutegravir-based Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 (HIV-2) Infection: Progress for People Living With HIV-2
    Gottlieb, Geoffrey S.
    CLINICAL INFECTIOUS DISEASES, 2023, 77 (05) : 749 - 751
  • [10] Medroxyprogesterone acetate (MPA) concentrations among HIV-infected depot MPA (DMPA) users receiving tenofovir antiretroviral therapy (art) in Lilongwe, Malawi
    Trivedi, S.
    Zia, Y.
    Tang, J.
    Lameck, C.
    Tegha, G.
    Kourtis, A.
    CONTRACEPTION, 2018, 98 (04) : 367 - 367
12345